Sovremennye predstavleniya o zhelezodefitsitnoy anemii u detey i vozmozhnostyakh ee korrektsii


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

The literature review presents the causes of iron deficiency anemia (IDA) in infants and adolescents, describes groups at risk of iron deficiency; particular attention is paid to the features of treatment of IDA using drugs containing iron salts and iron hydroxide-polymaltose complex. The criteria for the evaluation of the effectiveness of treatment of IDA and causes of treatment failure are presented. It is recommended to follow the principles of primary and secondary prevention of iron deficiency that can lead to a significant decline in its prevalence.

全文:

受限制的访问

参考

  1. Хертл М. Дифференциальная диагностика в педиатрии. Пер. с нем. М., 1990. Т. 2. 510 с.
  2. Tanner J.M., Whitehouse R.H., Takaishi M. Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. I. Arch. Dis. Child. 1966; 41(219): 454-71.
  3. Baker R.D., Greer F.R. Committee on Nutrition American Academy of Pediatrics. Diagnosis and prevention of iron deficiency and iron-deficiency anemia in infants and young children (0-3 years of age). Pediatrics. 2010; 126(5): 1040-50.
  4. Recommendation to prevent and control iron deficiency in the United States. MMWR Recomm. Rep. 1998; 47(RR-3): 1-29.
  5. Lozoff B., Wolf A.W., Jimenez E. Iron-deficiency anemia and infant development: effects of extended oral iron therapy. J. Pediatr. 1996; 129(3): 382-89.
  6. Lozoff B., Klein N.K., Nelson E.C., et al. Behavior of infants with iron-deficiency anemia. Child. Dev. 1998; 69(1): 24-36.
  7. Lozoff B. Perinatal iron deficiency and the developing brain. Pediatr. Res. 2000; 48(2): 137-39.
  8. Lozoff B., Jimenez E., Hagen J., Mollen E., Wolf A.W. Poorer behavioral and developmental outcome more than 10 years after treatment for iron deficiency in infancy. Pediatrics. 2000; 105(4): E51.
  9. Grantham-McGregor S., Ani C. A review of studies on the effect of iron deficiency on cognitive development in children. J. Nutr. 2001; 131(2S-2): 649S-66S.
  10. Регистр лекарственных средств России. Энциклопедия лекарств. Ежегодный сборник: htpp://www.rlsnet.ru.
  11. Vidal 2011. Справочник Видаль. Лекарственные препараты в России. М., 2011.
  12. Кольцов О.В. Особенности клинической картины, диагностики и лечения случайных отравлений ферросодержащими препаратами у детей. Дисс.. канд. мед. наук. Новосибирск, 2002. 18 с.
  13. Tobili J.E., Brignoli R. Iron(III)-hydroxide polymaltose complex in iron deficiency anemia (review and meta-analysis). Arzneimittel Forschung. 2007; 57(6a): 431-38.
  14. Geisser P. Safety and efficacy of iron (III) -hydroxide polymaltose complex. A review of over 25 years of experience. Arzneimittel Forschung. 2007; 57(6a): 439-52.
  15. Румянцев А.Г., Коровина Н.А., Чернов В.М. и др. Диагностика и лечение железодефицитной анемии у детей. Методическое пособие для врачей. М., 2004. 45 с.
  16. Finberg K.E., Heeney M.M., Campagna D.R., et al. Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA). Nat. Genet. 200; 40(5): 569-71.
  17. Pellegrino R.M., Coutinho M., D'Ascola D., et al. Two novel mutations in the tmprss6 gene associated with iron-refractory iron-deficiency anaemia (irida) and partial expression in the heterozygous form. Br. J. Haematol. 2012; 158(5): 668-72.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bionika Media, 2014
##common.cookie##